登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 16636 条符合本次的查询结果， 用时 0.9197344 秒

241. Cardiology Societies Urge Action on Environmental Risk Factors.

作者: Samantha Anderer.
来源: JAMA. 2026年335卷10期838-839页

242. US Completes Withdrawal From the WHO.

作者: Samantha Anderer.
来源: JAMA. 2026年335卷10期841页

243. Stroke Guideline Expands Adult Treatment, Provides Pediatric Recommendations.

作者: Samantha Anderer.
来源: JAMA. 2026年335卷10期840页

244. AAP Releases Its Own Childhood and Adolescent Immunization Schedule.

作者: Samantha Anderer.
来源: JAMA. 2026年335卷10期840-841页

245. US Life Expectancy Rebounds to Prepandemic High.

作者: Samantha Anderer.
来源: JAMA. 2026年335卷10期840页

246. Measles Outbreak Worsens in South Carolina.

作者: Samantha Anderer.
来源: JAMA. 2026年335卷10期840页

247. US Patients Getting ICEd-Out of Health Care.

作者: Rita Rubin.
来源: JAMA. 2026年335卷10期835-837页

248. Maternal Syphilis Continues to Rise.

作者: Samantha Anderer.
来源: JAMA. 2026年335卷10期840页

249. Pharmaceutical Pricing-JAMA Talks With Mark Cuban.

作者: Kirsten Bibbins-Domingo.
来源: JAMA. 2026年335卷10期e2525505页

250. Outcomes of Same-Sex Female Couples Pursuing Autologous and Reciprocal In Vitro Fertilization.

作者: Daniela Diego.;Audrey J Gaskins.;Heather S Hipp.;Jennifer F Kawwass.
来源: JAMA. 2026年335卷10期905-907页

251. Syphilis and Cerebrospinal Fluid Examination.

作者: Javier Velasco Montes.;Silvia González Díez.
来源: JAMA. 2026年335卷11期1007页

252. Medicare Advantage and Quality Measurement-A System at Risk.

作者: Adam A Markovitz.;Eve A Kerr.;Jeffrey A Buck.
来源: JAMA. 2026年335卷11期937-938页

253. Stumbling Toward AI in the Clinic.

作者: Roy Perlis.
来源: JAMA. 2026年335卷10期e2523768页

254. Syphilis and Cerebrospinal Fluid Examination-Reply.

作者: Franco J Chevalier.;Kelly A Johnson.;Stephanie E Cohen.
来源: JAMA. 2026年335卷11期1007-1008页

255. Fatigue and Disease.

来源: JAMA. 2026年335卷10期914页

256. When Protocol Meets Reality.

作者: Wesley Burks.
来源: JAMA. 2026年335卷11期943-944页

257. Buprenorphine in the ED-Balancing Access, Safety, and Autonomy.

作者: Jessica Moe.;Andrew Kestler.;Isabelle Miles.
来源: JAMA. 2026年335卷11期945-947页

258. Medications for Opioid Use Disorder, Opioid Withdrawal, and Opioid Overdose: A Review.

作者: Miriam T H Harris.;Zoe M Weinstein.;Alexander Y Walley.
来源: JAMA. 2026年335卷11期986-998页
Opioid use disorder (OUD) involves compulsive opioid use that causes substantial distress or impairment at work, school, or home. OUD, which is the third most prevalent substance use disorder worldwide, affected an estimated 3.7% of US adults (9 367 000) in 2022 and caused 53 774 deaths in the US in 2024. Medications for opioid use disorder (MOUD) reduce morbidity and mortality. Individuals with OUD also benefit from medications to treat opioid withdrawal and reverse acute opioid overdose.

259. Emergency Department-Initiated Buprenorphine for Opioid Use Disorder: Research Summary.

来源: JAMA. 2026年335卷11期e2527064页

260. Food Ingredients, State Actions, and Federal Preemption.

作者: Jennifer L Pomeranz.;Emily M Broad Leib.;Dariush Mozaffarian.
来源: JAMA. 2026年335卷10期843-844页
共有 16636 条符合本次的查询结果， 用时 0.9197344 秒